1 December 2024 false Taxfiler 2024.6 3631732 business:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 3631732 2024-11-30 3631732 2024-12-01 2025-11-30 3631732 business:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 3631732 business:FilletedAccounts 2024-12-01 2025-11-30 3631732 2025-11-30 3631732 business:Director1 2024-12-01 2025-11-30 3631732 business:Director2 2024-12-01 2025-11-30 3631732 business:CompanySecretary1 2024-12-01 2025-11-30 3631732 business:RegisteredOffice 2024-12-01 2025-11-30 3631732 2024-11-30 3631732 core:WithinOneYear 2025-11-30 3631732 core:WithinOneYear 2024-11-30 3631732 core:AfterOneYear 2025-11-30 3631732 core:AfterOneYear 2024-11-30 3631732 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 3631732 core:ShareCapital core:PreviouslyStatedAmount 2024-11-30 3631732 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-11-30 3631732 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-11-30 3631732 core:PreviouslyStatedAmount 2025-11-30 3631732 core:PreviouslyStatedAmount 2024-11-30 3631732 business:SmallEntities 2024-12-01 2025-11-30 3631732 countries:EnglandWales 2024-12-01 2025-11-30 3631732 core:Goodwill 2024-11-30 3631732 core:Goodwill 2024-12-01 2025-11-30 3631732 core:Goodwill 2025-11-30 3631732 business:OrdinaryShareClass1 2024-12-01 2025-11-30 3631732 business:OrdinaryShareClass1 2023-12-01 2024-11-30 3631732 business:OrdinaryShareClass2 2024-12-01 2025-11-30 3631732 business:OrdinaryShareClass2 2023-12-01 2024-11-30 3631732 business:AllOrdinaryShares 2024-12-01 2025-11-30 3631732 business:AllOrdinaryShares 2023-12-01 2024-11-30 3631732 2023-12-01 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 3631732 (England and Wales)
ADVANCE PHARMACIES LTD Unaudited accounts for the year ended 30 November 2025
ADVANCE PHARMACIES LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
ADVANCE PHARMACIES LTD Company Information for the year ended 30 November 2025
Directors
Nadeem Iqbal Mazair Iqbal
Secretary
Mazair Iqbal
Company Number
3631732 (England and Wales)
Registered Office
188 Lichfield Road Rushall Walsall West Midlands WS4 1ED England
Accountants
Caldwell House Consulting 44 Caldwell Road Birmingham West Midlands B9 5TQ
- 3 -
ADVANCE PHARMACIES LTD Statement of financial position as at 30 November 2025
2025
2024
Notes
£
£
Fixed assets
Intangible assets
4
320,000
310,000
Current assets
Inventories
35,508
-
Debtors
5
396,294
362,571
Cash at bank and in hand
990,973
1,330,054
1,422,775
1,692,625
Creditors: amounts falling due within one year
6
(312,977)
(86,009)
Net current assets
1,109,798
1,606,616
Total assets less current liabilities
1,429,798
1,916,616
Creditors: amounts falling due after more than one year
7
(1,340,989)
(1,758,165)
Net assets
88,809
158,451
Capital and reserves
Called up share capital
8
200
200
Profit and loss account
88,609
158,251
Shareholders' funds
88,809
158,451
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 15 May 2026 and were signed on its behalf by
Mazair Iqbal Director Company Registration No. 3631732
- 4 -
ADVANCE PHARMACIES LTD Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
ADVANCE PHARMACIES LTD is a private company, limited by shares, registered in England and Wales, registration number 3631732. The registered office is 188 Lichfield Road, Rushall, Walsall, West Midlands, WS4 1ED, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
4
Intangible fixed assets
Goodwill
£
Cost
At 1 December 2024
310,000
Additions
320,000
Disposals
(310,000)
At 30 November 2025
320,000
Amortisation
At 1 December 2024
-
At 30 November 2025
-
Net book value
At 30 November 2025
320,000
At 30 November 2024
310,000
5
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
62,299
275,798
Trade debtors
333,995
86,773
396,294
362,571
- 5 -
ADVANCE PHARMACIES LTD Notes to the Accounts for the year ended 30 November 2025
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
290,096
61,173
Taxes and social security
6,171
11,234
Other creditors
16,710
13,602
312,977
86,009
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
1,340,989
1,758,165
8
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
100 Ordinary shares - B of £1 each
100
100
200
200
9
Average number of employees
During the year the average number of employees was 7 (2024: 17).
- 6 -